A Phase (Ph) III clinical program: 1L atezolizumab (atezo) plus chemotherapy (chemo) in chemo-naive advanced NSCLC Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Mok, T. S. K.; Jotte, R. M.; Cappuzzo, F.; Reck, M.; Papadimitrakopoulou, V.; West, H. J.; Sandler, A.; Mocci, S.; Coleman, S.; Asakawa, T.; Socinski, M. A.

authors

Publication Date

  • December 1, 2016

webpage

published in

category

volume

  • 27